Related Experiment Video
Updated: May 13, 2026
09:09
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
Switchable delivery of small interfering RNA using a negatively charged pH-responsive polyethylenimine-based
S-Ja Tseng1, Yi-Fang Zeng, Yu-Fan Deng
1Institute of Physics, Academia Sinica, Taipei 115, Taiwan.
Chemical Communications (Cambridge, England)
|February 26, 2013
Summary
Researchers developed a novel polyelectrolyte delivery system using branched polyethylenimine (bPEI) and copolymers to precisely target tumors. This system releases small interfering RNA (siRNA) in response to acidic tumor environments, minimizing harm to healthy cells.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Tumor microenvironments often exhibit acidosis, which can be exploited for targeted therapies.
- Developing effective delivery systems for small interfering RNA (siRNA) remains a challenge due to stability and targeting issues.
- Branched polyethylenimine (bPEI) is a known non-viral vector for gene delivery, but often exhibits cytotoxicity.
Purpose of the Study:
- To engineer a tumor acidosis-triggered delivery system for siRNA.
- To reduce the cytotoxicity associated with traditional polyethylenimine-based vectors.
- To create a polyelectrolyte complex using bPEI and functional copolymers for enhanced therapeutic delivery.
Main Methods:
- Synthesis of copolymers incorporating polyethylene glycol (PEG), histidine (His), and glutamic acid (Glu).
- Construction of a polyelectrolyte complex encapsulating siRNA using branched polyethylenimine (bPEI) and the synthesized copolymers.
- Evaluation of the delivery system's response to acidic conditions mimicking tumor acidosis.
- Assessment of cytotoxicity in vitro and in vivo.
Main Results:
- The developed polyelectrolyte system successfully encapsulated siRNA.
- The system demonstrated triggered release of siRNA in response to acidic pH.
- Incorporation of PEG, His, and Glu modified the bPEI properties, leading to reduced cytotoxicity.
- Preliminary data suggests effective delivery to tumor cells under acidic conditions.
Conclusions:
- A novel siRNA-loaded polyelectrolyte system responsive to tumor acidosis was successfully developed.
- The combination of bPEI with PEGylated, His- and Glu-containing copolymers offers a promising strategy for targeted siRNA delivery with improved safety.
- This approach holds potential for developing advanced cancer therapeutics with reduced side effects.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...